SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-13-003854
Filing Date
2013-06-03
Accepted
2013-05-31 17:51:02
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2369454
2 filename2.htm EX-10.1 83034
3 filename3.htm EX-10.5 67520
4 filename4.htm EX-10.6 66930
5 filename5.htm EX-10.7 66266
6 filename6.htm EX-10.8 64932
7 GRAPHIC g483126g90c25.jpg GRAPHIC 43524
8 GRAPHIC g483126g06y10.jpg GRAPHIC 39915
9 GRAPHIC g483126g36d61.jpg GRAPHIC 30822
10 GRAPHIC g483126g44k50.jpg GRAPHIC 50528
11 GRAPHIC g483126g60q01.jpg GRAPHIC 23229
12 GRAPHIC g483126g69p67.jpg GRAPHIC 86996
13 GRAPHIC g483126g74p89.jpg GRAPHIC 60110
14 GRAPHIC g483126g77c95.jpg GRAPHIC 24018
15 GRAPHIC g483126g82w61.jpg GRAPHIC 33007
16 GRAPHIC g483126g88p91.jpg GRAPHIC 72307
17 GRAPHIC g483126g88s00.jpg GRAPHIC 32256
  Complete submission text file 0000950123-13-003854.txt   3405186
Mailing Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112
Business Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 267-546-3003
Iroko Pharmaceuticals Inc. (Filer) CIK: 0001566717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00120 | Film No.: 13886125
SIC: 2834 Pharmaceutical Preparations